Spandidos Publications style
Wang ZG, Fukazawa T, Nishikawa T, Watanabe N, Sakurama K, Motoki T, Takaoka M, Hatakeyama S, Omori O, Ohara T, Ohara T, et al: TAE226, a dual inhibitor for FAK and IGF-IR, has inhibitory effects on mTOR signaling in esophageal cancer cells. Oncol Rep 20: 1473-1477, 2008.
APA
Wang, Z.G., Fukazawa, T., Nishikawa, T., Watanabe, N., Sakurama, K., Motoki, T. ... Naomoto, Y. (2008). TAE226, a dual inhibitor for FAK and IGF-IR, has inhibitory effects on mTOR signaling in esophageal cancer cells. Oncology Reports, 20, 1473-1477. https://doi.org/10.3892/or_00000168
MLA
Wang, Z. G., Fukazawa, T., Nishikawa, T., Watanabe, N., Sakurama, K., Motoki, T., Takaoka, M., Hatakeyama, S., Omori, O., Ohara, T., Tanabe, S., Fujiwara, Y., Shirakawa, Y., Yamatsuji, T., Tanaka, N., Naomoto, Y."TAE226, a dual inhibitor for FAK and IGF-IR, has inhibitory effects on mTOR signaling in esophageal cancer cells". Oncology Reports 20.6 (2008): 1473-1477.
Chicago
Wang, Z. G., Fukazawa, T., Nishikawa, T., Watanabe, N., Sakurama, K., Motoki, T., Takaoka, M., Hatakeyama, S., Omori, O., Ohara, T., Tanabe, S., Fujiwara, Y., Shirakawa, Y., Yamatsuji, T., Tanaka, N., Naomoto, Y."TAE226, a dual inhibitor for FAK and IGF-IR, has inhibitory effects on mTOR signaling in esophageal cancer cells". Oncology Reports 20, no. 6 (2008): 1473-1477. https://doi.org/10.3892/or_00000168
